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T
he  most  important  enzymes  of  detoxication 
are  cytochromes  P450  of  Phase  I  and  UDP-
glucuronosyltransferases  of  Phase  II  of  drug 
metabolism. The conventional division of drug, or xeno-
biotic, metabolism to two phases has survived almost fifty 
years and although not perfect, still is rather informative 
and practical. The recent addition of the next, third phase 
to the first two (Phase I as yielding a molecule with free 
functional  groups  ready  for  conjugation  with  another 
molecule or its part in Phase II) stressed the importance of 
drug transport across the membranes even if it is not a pure 
metabolic process (i.e. a process changing the polarity and 
structure of a compound). 
The importance of testing the toxicity of newly invented 
drugs and drug candidates is also given by the simple fact 
that it is the toxicity and unwanted pharmacokinetics incl. 
interactions  which  is  the  reason  for  declination  of  one 
half of new or promising compounds. All other reasons as 
low efficacy, adverse effects, marketing and commercial 
reasons, and other reasons are responsible for the second 
half of the rejections (Van de Waterbeemd & Gifford, 2003). 
According to the recent view of the regulation authorities, 
the in vitro testing of drug metabolism of any new chemical 
entity should be realized together with an evaluation of its 
interaction with the system of drug transporters, mainly 
with the ABC membrane based protein pumps which often 
decide on the drug bioavailability.
The majority of known cases of drug toxicity are however 
ascribed to reactions in which the catalytic processes involv-
ing cytochromes P450 are involved. The death toll caused by 
malignant arrhythmias due to increased level of terfenadine 
or astemizole is well documented and is a part of each 
modern textbook of pharmacology and toxicology. Also, the 
recent case of mibefradil which has been withdrawn from 
the market by the company two years after successful intro-
duction is also well known. In all cases, increased levels of 
the drug were caused by interactions with other drugs, com-
peting for the same form of cytochrome P450. Cytochromes 
P450 are also known for their two-sided behavior often com-
pared with Dr. Jekyll and Mr. Hyde of the R. L. Stevenson´s 
novel: The same form is responsible for detoxication pro-
cessess as well as by activation of a carcinogen or a toxicant, 
in principle, by the same type of chemical reaction, i.e. by 
activation of molecular oxygen. It is of course not the fault 
of the cytochromes P450, but our own – as the enzyme is 
simply performing the same role independently on our wish.
The ways and approaches used for in vitro studies of 
processes in which cytochromes P450 take place can be 
divided  according  to  the  degree  of  organization  of  the 
system studied. From the most simple to the most complex, 
the first system should comprise only the molecules of the 
enzyme with the necessary components assuring the proper 
assembly and function. 
Reconstituted Systems, Bactosomes et al.
These so-called “reconstituted systems” with cytochromes 
P450 should at first include the studied form of cytochrome 
P450,  the  NADPH:cytochrome  P450  oxidoreductase, 
NADPH as the source of electrons (or a system generating 
the NADPH as the NADP, isocitrate and isocitrate dehydro-
genase or alternatively again the NADP, and glucose-6-phos-
phate together with glucose 6-phosphate dehydrogenase). 
Also, a phospholipid is necessary to form a moiety similar 
to the membrane of endoplasmic reticulum. Similarly, the 
reconstituted systems are prepared with specified forms of 
UDP-glucuronosyltransferase, or with the sulfotransferase 
or other enzymes to study the second phase of xenobiotic 
metabolism (Shimada & Yamazaki, 1998; Green & Tephly, 
1998).
An  alternative  to  these  reconstituted  systems  is  the 
use of membrane preparations of mostly bacterial origin 
expressing only a single form of cytochrome P450, but 
together with the NADPH:cytochrome P450 oxidoreductase 
supplying the necessary electrons. As with the reconstituted 
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systems, a surplus of the NADPH or a NADPH generating 
system must be added. An advantage of these recombi-
nant systems is certainly the fact, that the enzymes are 
embedded  in  the  membrane  and  that  no  addition  of  a 
phospholipid as well as preparation of a vesicular system by 
ultrasound is needed (See e.g. web sites www.cypex.co.uk 
(bactosomes),  www.bdbiosciences.com  (supersomes), 
www.invitrogen.com (baculosomes)).
Studies with reconstituted systems and with membrane-
ous systems containing single form of cytochrome P450 are 
complex as the composition and even the mode of prepara-
tion (e.g. sequence of components added) of the reaction 
mixture can significantly affect the efficacy of the system. 
On the other hand, these systems are the only way how to 
confirm that a particular, selected enzyme is involved in 
the biotransformation of the substance studied and that it 
forms the desired products (either more or less toxic or with 
unchanged toxicity). 
Microsomes
Microsomes, i.e. microsomal fraction of cell homogenate 
(most frequently liver microsomes formed from hepato-
cytes) are artificial systems formed during cell disruption 
and obtained by differential centrifugation (Schenkman 
& Jansson, 1998). The most important point is that the 
“microsomes” maintain the orientation of the endoplas-
matic reticulum from which they are formed. Studies with 
microsomes need addition of NADPH or of the NADPH 
generating system as the amount of this coenzyme in the 
microsomal preparation is quickly depleted during the reac-
tion. Liver microsomal enzymes are not only cytochromes 
P450, but also e.g. flavin monooxygenases, xanthin oxidase, 
quinone  oxidoreductase,  as  well  as  several  enzymes  of 
the conjugation phase of xenobiotic metabolism as UDP 
glucuronosyltransferases (families UGT1A, UGT2B) and 
others. Hence, the reaction performed in this system yields 
products of several enzymes and the analysis is more com-
plex. Hence, an inhibition of specific activities of selected 
enzymes should be used to find the enzyme system or a par-
ticular form of enzyme (e.g. of the cytochrome P450) which is 
involved in an interaction with the compound studied. This 
way, the “suspected” enzyme or enzyme form can be selected. 
Also, a reverse attitude can be used – when a metabolite is 
formed, the addition of a specific inhibitor of a particular 
enzyme can influence its formation (Jančová et al., 2007). 
The microsomes are by no means still the most widely used 
system in studies of xenobiotic metabolism and toxicity.
Hepatocytes
Cellular systems, as liver hepatocytes, are more and more 
frequently used. The commercial availability of hepatocytes 
from defined sources makes their use rather easy. In this 
respect, freshly thawn cells according to the supplier’s rec-
ommendation are the best solution for laboratories which 
do not have access to cell culture laboratory. Alternatively, a 
freshly prepared suspension of hepatocytes can be used for 
limited time (not exceeding two hours) after disruption of 
the organ. Hepatocytes itself represent even more complex 
system than microsomes which however mimic well the 
situation on the organism (Ferrini et al., 1998). 
The  most  of  prime  selection  and  pilot  toxicological 
studies usually stop at this degree of complexity. For human 
use, a toxicity study on model experimental animal is still 
necessary. The realization of such an experiment and the 
selection of an appropriate model are however beyond the 
scope of this introduction.
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